 | • レポートコード：QAF27743 • 出版社/出版日：QYResearch / 2021年4月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のインスリングラルギン市場について種類別（単回投与用バイアル、プレフィルドシリンジ）、用途別（2型糖尿病治療、1型糖尿病治療）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・インスリングラルギン市場の概要 ・世界の主要地域別インスリングラルギン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のインスリングラルギン市場規模2016-2021：種類別（単回投与用バイアル、プレフィルドシリンジ） ・世界のインスリングラルギン市場予測2012-2027：種類別（単回投与用バイアル、プレフィルドシリンジ） ・世界のインスリングラルギン市場規模2016-2021：用途別（2型糖尿病治療、1型糖尿病治療） ・世界のインスリングラルギン市場予測2012-2027：用途別（2型糖尿病治療、1型糖尿病治療） ・インスリングラルギンのアメリカ市場規模と予測2016-2021 ・インスリングラルギンのヨーロッパ市場規模と予測2016-2021 ・インスリングラルギンの中国市場規模と予測2016-2021 ・インスリングラルギンの日本市場規模と予測2016-2021 ・インスリングラルギンの東南アジア市場規模と予測2016-2021 ・インスリングラルギンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi-Aventis、Ganlee、Biocon） ・インスリングラルギンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インスリングラルギンの市場動向・機会・課題 ・調査の結論 |
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a “peakless” profile (according to the insulin glargine package insert).
Insulin glargine is a long-acting, man-made version of human insulin. Insulin glargine works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is Used for energy. It also stops the liver from producing more sugar.
There are two type of Insulin glargine, which are Single Dose Vial and Pre-filled Syringe in the market. Considering its function, Insulin glargine is Used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also Used to treat people with type 2 diabetes (condition in which the body does not Used insulin normally and, therefore, cannot control the amount of sugar in the blood) who need insulin to control their diabetes.
We can see that there are just a few companies produce Insulin glargine, the production of them almost approach to 70% of whole market. They have seted plant in Japan, China, German, India, North Americato produce Insulin glargine, and China is the largest plant for Insulin glargine in the world and also the largest consumption country. As the amount of diabetes of increasing of China, the Chinese market will be bigger than North America.
The Industry is affected by the economic development level and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to care about personal health, especially in underdevelopment regions that have a large population and fast economic growth, the need of Insulin glargine will increase.
Market Analysis and Insights: Global Insulin Glargine Market
The global Insulin Glargine market was valued at US$ 6698.7 in 2020 and will reach US$ 8476 million by the end of 2027, growing at a CAGR of 4.0% during 2022-2027.
Global Insulin Glargine Scope and Market Size
The global Insulin Glargine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Glargine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Single Dose Vial
Pre-filled Syringe
Segment by Application
Treat Type2 Diabetes
Treat Type1 Diabetes
The Insulin Glargine market is analysed and market size information is provided by regions (countries). Segment by Application, the Insulin Glargine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Sanofi-Aventis
Ganlee
Biocon
1 Insulin Glargine Market Overview
1.1 Insulin Glargine Product Scope
1.2 Insulin Glargine Segment by Type
1.2.1 Global Insulin Glargine Sales by Type (2016 & 2021 & 2027)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Insulin Glargine Segment by Application
1.3.1 Global Insulin Glargine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Treat Type2 Diabetes
1.3.3 Treat Type1 Diabetes
1.4 Insulin Glargine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Insulin Glargine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Insulin Glargine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Insulin Glargine Price Trends (2016-2027)
2 Insulin Glargine Estimates and Forecasts by Region
2.1 Global Insulin Glargine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Insulin Glargine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Insulin Glargine Sales Market Share by Region (2016-2021)
2.2.2 Global Insulin Glargine Revenue Market Share by Region (2016-2021)
2.3 Global Insulin Glargine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Insulin Glargine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Insulin Glargine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Insulin Glargine Estimates and Projections (2016-2027)
2.4.2 Europe Insulin Glargine Estimates and Projections (2016-2027)
2.4.3 China Insulin Glargine Estimates and Projections (2016-2027)
2.4.4 Japan Insulin Glargine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Insulin Glargine Estimates and Projections (2016-2027)
2.4.6 India Insulin Glargine Estimates and Projections (2016-2027)
3 Global Insulin Glargine Competition Landscape by Players
3.1 Global Top Insulin Glargine Players by Sales (2016-2021)
3.2 Global Top Insulin Glargine Players by Revenue (2016-2021)
3.3 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Glargine as of 2020)
3.4 Global Insulin Glargine Average Price by Company (2016-2021)
3.5 Manufacturers Insulin Glargine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Insulin Glargine Market Size by Type
4.1 Global Insulin Glargine Historic Market Review by Type (2016-2021)
4.1.1 Global Insulin Glargine Sales Market Share by Type (2016-2021)
4.1.2 Global Insulin Glargine Revenue Market Share by Type (2016-2021)
4.1.3 Global Insulin Glargine Price by Type (2016-2021)
4.2 Global Insulin Glargine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Insulin Glargine Sales Forecast by Type (2022-2027)
4.2.2 Global Insulin Glargine Revenue Forecast by Type (2022-2027)
4.2.3 Global Insulin Glargine Price Forecast by Type (2022-2027)
5 Global Insulin Glargine Market Size by Application
5.1 Global Insulin Glargine Historic Market Review by Application (2016-2021)
5.1.1 Global Insulin Glargine Sales Market Share by Application (2016-2021)
5.1.2 Global Insulin Glargine Revenue Market Share by Application (2016-2021)
5.1.3 Global Insulin Glargine Price by Application (2016-2021)
5.2 Global Insulin Glargine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Insulin Glargine Sales Forecast by Application (2022-2027)
5.2.2 Global Insulin Glargine Revenue Forecast by Application (2022-2027)
5.2.3 Global Insulin Glargine Price Forecast by Application (2022-2027)
6 North America Insulin Glargine Market Facts & Figures
6.1 North America Insulin Glargine Sales by Company
6.1.1 North America Insulin Glargine Sales by Company (2016-2021)
6.1.2 North America Insulin Glargine Revenue by Company (2016-2021)
6.2 North America Insulin Glargine Sales Breakdown by Type
6.2.1 North America Insulin Glargine Sales Breakdown by Type (2016-2021)
6.2.2 North America Insulin Glargine Sales Breakdown by Type (2022-2027)
6.3 North America Insulin Glargine Sales Breakdown by Application
6.3.1 North America Insulin Glargine Sales Breakdown by Application (2016-2021)
6.3.2 North America Insulin Glargine Sales Breakdown by Application (2022-2027)
7 Europe Insulin Glargine Market Facts & Figures
7.1 Europe Insulin Glargine Sales by Company
7.1.1 Europe Insulin Glargine Sales by Company (2016-2021)
7.1.2 Europe Insulin Glargine Revenue by Company (2016-2021)
7.2 Europe Insulin Glargine Sales Breakdown by Type
7.2.1 Europe Insulin Glargine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Insulin Glargine Sales Breakdown by Type (2022-2027)
7.3 Europe Insulin Glargine Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Insulin Glargine Market Facts & Figures
8.1 China Insulin Glargine Sales by Company
8.1.1 China Insulin Glargine Sales by Company (2016-2021)
8.1.2 China Insulin Glargine Revenue by Company (2016-2021)
8.2 China Insulin Glargine Sales Breakdown by Type
8.2.1 China Insulin Glargine Sales Breakdown by Type (2016-2021)
8.2.2 China Insulin Glargine Sales Breakdown by Type (2022-2027)
8.3 China Insulin Glargine Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Insulin Glargine Market Facts & Figures
9.1 Japan Insulin Glargine Sales by Company
9.1.1 Japan Insulin Glargine Sales by Company (2016-2021)
9.1.2 Japan Insulin Glargine Revenue by Company (2016-2021)
9.2 Japan Insulin Glargine Sales Breakdown by Type
9.2.1 Japan Insulin Glargine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Insulin Glargine Sales Breakdown by Type (2022-2027)
9.3 Japan Insulin Glargine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Insulin Glargine Market Facts & Figures
10.1 Southeast Asia Insulin Glargine Sales by Company
10.1.1 Southeast Asia Insulin Glargine Sales by Company (2016-2021)
10.1.2 Southeast Asia Insulin Glargine Revenue by Company (2016-2021)
10.2 Southeast Asia Insulin Glargine Sales Breakdown by Type
10.2.1 Southeast Asia Insulin Glargine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Insulin Glargine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Insulin Glargine Sales Breakdown by Application
10.3.1 Southeast Asia M mL Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M mL Sales Breakdown by Application (2022-2027)
11 India Insulin Glargine Market Facts & Figures
11.1 India Insulin Glargine Sales by Company
11.1.1 India Insulin Glargine Sales by Company (2016-2021)
11.1.2 India Insulin Glargine Revenue by Company (2016-2021)
11.2 India Insulin Glargine Sales Breakdown by Type
11.2.1 India Insulin Glargine Sales Breakdown by Type (2016-2021)
11.2.2 India Insulin Glargine Sales Breakdown by Type (2022-2027)
11.3 India Insulin Glargine Sales Breakdown by Application
11.3.1 India Insulin Glargine Sales Breakdown by Application (2016-2021)
11.3.2 India Insulin Glargine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Insulin Glargine Business
12.1 Sanofi-Aventis
12.1.1 Sanofi-Aventis Corporation Information
12.1.2 Sanofi-Aventis Business Overview
12.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi-Aventis Insulin Glargine Products Offered
12.1.5 Sanofi-Aventis Recent Development
12.2 Ganlee
12.2.1 Ganlee Corporation Information
12.2.2 Ganlee Business Overview
12.2.3 Ganlee Insulin Glargine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Ganlee Insulin Glargine Products Offered
12.2.5 Ganlee Recent Development
12.3 Biocon
12.3.1 Biocon Corporation Information
12.3.2 Biocon Business Overview
12.3.3 Biocon Insulin Glargine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biocon Insulin Glargine Products Offered
12.3.5 Biocon Recent Development
…
13 Insulin Glargine Manufacturing Cost Analysis
13.1 Insulin Glargine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Insulin Glargine
13.4 Insulin Glargine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Insulin Glargine Distributors List
14.3 Insulin Glargine Customers
15 Market Dynamics
15.1 Insulin Glargine Market Trends
15.2 Insulin Glargine Drivers
15.3 Insulin Glargine Market Challenges
15.4 Insulin Glargine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Insulin Glargine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Insulin Glargine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Insulin Glargine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Insulin Glargine Sales (M mL) by Region (2016-2021)
Table 5. Global Insulin Glargine Sales Market Share by Region (2016-2021)
Table 6. Global Insulin Glargine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Insulin Glargine Revenue Share by Region (2016-2021)
Table 8. Global Insulin Glargine Sales (M mL) Forecast by Region (2022-2027)
Table 9. Global Insulin Glargine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Insulin Glargine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Insulin Glargine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Insulin Glargine Sales (M mL) of Key Companies (2016-2021)
Table 13. Global Insulin Glargine Sales Share by Company (2016-2021)
Table 14. Global Insulin Glargine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Insulin Glargine Revenue Share by Company (2016-2021)
Table 16. Global Insulin Glargine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Glargine as of 2020)
Table 17. Global Insulin Glargine Average Price (USD/mL) of Key Company (2016-2021)
Table 18. Manufacturers Insulin Glargine Manufacturing Sites and Area Served
Table 19. Manufacturers Insulin Glargine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Insulin Glargine Sales (M mL) by Type (2016-2021)
Table 22. Global Insulin Glargine Sales Share by Type (2016-2021)
Table 23. Global Insulin Glargine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Insulin Glargine Price (USD/mL) by Type (2016-2021)
Table 25. Global Insulin Glargine Sales Share by Type (2022-2027)
Table 26. Global Insulin Glargine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Insulin Glargine Revenue Share by Type (2022-2027)
Table 28. Global Insulin Glargine Price (USD/mL) by Type (2022-2027)
Table 29. Global Insulin Glargine Sales (M mL) by Application (2016-2021)
Table 30. Global Insulin Glargine Sales Share by Application (2016-2021)
Table 31. Global Insulin Glargine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Insulin Glargine Price (USD/mL) by Application (2016-2021)
Table 33. Global Insulin Glargine Sales (M mL) by Application (2022-2027)
Table 34. Global Insulin Glargine Sales Share by Application (2022-2027)
Table 35. Global Insulin Glargine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Insulin Glargine Revenue Share by Application (2022-2027)
Table 37. Global Insulin Glargine Price (USD/mL) by Application (2022-2027)
Table 38. North America Insulin Glargine Sales (M mL) by Company (2016-2021)
Table 39. North America Insulin Glargine Sales Market Share by Company (2016-2021)
Table 40. North America Insulin Glargine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Insulin Glargine Revenue Market Share by Company (2016-2021)
Table 42. North America Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 43. North America Insulin Glargine Sales Market Share by Type (2016-2021)
Table 44. North America Insulin Glargine Sales by Type (2022-2027) & (M mL)
Table 45. North America Insulin Glargine Sales Market Share by Type (2022-2027)
Table 46. North America Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 47. North America Insulin Glargine Sales Market Share by Application (2016-2021)
Table 48. North America Insulin Glargine Sales by Application (2022-2027) & (M mL)
Table 49. North America Insulin Glargine Sales Market Share by Application (2022-2027)
Table 50. Europe Insulin Glargine Sales (M mL) by Company (2016-2021)
Table 51. Europe Insulin Glargine Sales Market Share by Company (2016-2021)
Table 52. Europe Insulin Glargine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Insulin Glargine Revenue Market Share by Company (2016-2021)
Table 54. Europe Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 55. Europe Insulin Glargine Sales Market Share by Type (2016-2021)
Table 56. Europe Insulin Glargine Sales by Type (2022-2027) & (M mL)
Table 57. Europe Insulin Glargine Sales Market Share by Type (2022-2027)
Table 58. Europe Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 59. Europe Insulin Glargine Sales Market Share by Application (2016-2021)
Table 60. Europe Insulin Glargine Sales by Application (2022-2027) & (M mL)
Table 61. Europe Insulin Glargine Sales Market Share by Application (2022-2027)
Table 62. China Insulin Glargine Sales (M mL) by Company (2016-2021)
Table 63. China Insulin Glargine Sales Market Share by Company (2016-2021)
Table 64. China Insulin Glargine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Insulin Glargine Revenue Market Share by Company (2016-2021)
Table 66. China Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 67. China Insulin Glargine Sales Market Share by Type (2016-2021)
Table 68. China Insulin Glargine Sales by Type (2022-2027) & (M mL)
Table 69. China Insulin Glargine Sales Market Share by Type (2022-2027)
Table 70. China Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 71. China Insulin Glargine Sales Market Share by Application (2016-2021)
Table 72. China Insulin Glargine Sales by Application (2022-2027) & (M mL)
Table 73. China Insulin Glargine Sales Market Share by Application (2022-2027)
Table 74. Japan Insulin Glargine Sales (M mL) by Company (2016-2021)
Table 75. Japan Insulin Glargine Sales Market Share by Company (2016-2021)
Table 76. Japan Insulin Glargine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Insulin Glargine Revenue Market Share by Company (2016-2021)
Table 78. Japan Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 79. Japan Insulin Glargine Sales Market Share by Type (2016-2021)
Table 80. Japan Insulin Glargine Sales by Type (2022-2027) & (M mL)
Table 81. Japan Insulin Glargine Sales Market Share by Type (2022-2027)
Table 82. Japan Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 83. Japan Insulin Glargine Sales Market Share by Application (2016-2021)
Table 84. Japan Insulin Glargine Sales by Application (2022-2027) & (M mL)
Table 85. Japan Insulin Glargine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Insulin Glargine Sales (M mL) by Company (2016-2021)
Table 87. Southeast Asia Insulin Glargine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Insulin Glargine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Insulin Glargine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 91. Southeast Asia Insulin Glargine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Insulin Glargine Sales by Type (2022-2027) & (M mL)
Table 93. Southeast Asia Insulin Glargine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 95. Southeast Asia Insulin Glargine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Insulin Glargine Sales by Application (2022-2027) & (M mL)
Table 97. Southeast Asia Insulin Glargine Sales Market Share by Application (2022-2027)
Table 98. India Insulin Glargine Sales (M mL) by Company (2016-2021)
Table 99. India Insulin Glargine Sales Market Share by Company (2016-2021)
Table 100. India Insulin Glargine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Insulin Glargine Revenue Market Share by Company (2016-2021)
Table 102. India Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 103. India Insulin Glargine Sales Market Share by Type (2016-2021)
Table 104. India Insulin Glargine Sales by Type (2022-2027) & (M mL)
Table 105. India Insulin Glargine Sales Market Share by Type (2022-2027)
Table 106. India Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 107. India Insulin Glargine Sales Market Share by Application (2016-2021)
Table 108. India Insulin Glargine Sales by Application (2022-2027) & (M mL)
Table 109. India Insulin Glargine Sales Market Share by Application (2022-2027)
Table 110. Sanofi-Aventis Corporation Information
Table 111. Sanofi-Aventis Description and Business Overview
Table 112. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2016-2021)
Table 113. Sanofi-Aventis Insulin Glargine Product
Table 114. Sanofi-Aventis Recent Development
Table 115. Ganlee Corporation Information
Table 116. Ganlee Description and Business Overview
Table 117. Ganlee Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2016-2021)
Table 118. Ganlee Insulin Glargine Product
Table 119. Ganlee Recent Development
Table 120. Biocon Corporation Information
Table 121. Biocon Description and Business Overview
Table 122. Biocon Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2016-2021)
Table 123. Biocon Insulin Glargine Product
Table 124. Biocon Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Insulin Glargine Distributors List
Table 128. Insulin Glargine Customers List
Table 129. Insulin Glargine Market Trends
Table 130. Insulin Glargine Market Drivers
Table 131. Insulin Glargine Market Challenges
Table 132. Insulin Glargine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Glargine Product Picture
Figure 2. Global Insulin Glargine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Insulin Glargine Sales Market Share by Application in 2021 & 2027
Figure 6. Treat Type2 Diabetes Examples
Figure 7. Treat Type1 Diabetes Examples
Figure 8. Global Insulin Glargine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Insulin Glargine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Insulin Glargine Sales (M mL) Growth Rate (2016-2027)
Figure 11. Global Insulin Glargine Price Trends Growth Rate (2016-2027) (USD/mL)
Figure 12. Global Insulin Glargine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Insulin Glargine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Insulin Glargine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Insulin Glargine Sales (M mL) Growth Rate (2016-2027)
Figure 16. Europe Insulin Glargine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Insulin Glargine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Insulin Glargine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Insulin Glargine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Insulin Glargine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Insulin Glargine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Insulin Glargine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Insulin Glargine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Insulin Glargine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Insulin Glargine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Insulin Glargine Players Market Share by Revenue in Insulin Glargine: 2016 & 2020
Figure 27. Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Insulin Glargine Revenue Share by Type (2016-2021)
Figure 29. Global Insulin Glargine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Insulin Glargine Revenue Share by Application (2016-2021)
Figure 31. Global Insulin Glargine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Insulin Glargine Sales Market Share by Type in 2020
Figure 33. North America Insulin Glargine Sales Market Share by Application in 2020
Figure 34. Europe Insulin Glargine Sales Market Share by Type in 2020
Figure 35. Europe Insulin Glargine Sales Market Share by Application in 2020
Figure 36. China Insulin Glargine Sales Market Share by Type in 2020
Figure 37. China Insulin Glargine Sales Market Share by Application in 2020
Figure 38. Japan Insulin Glargine Sales Market Share by Type in 2020
Figure 39. Japan Insulin Glargine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Insulin Glargine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Insulin Glargine Sales Market Share by Application in 2020
Figure 42. India Insulin Glargine Sales Market Share by Type in 2020
Figure 43. India Insulin Glargine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Insulin Glargine
Figure 46. Manufacturing Process Analysis of Insulin Glargine
Figure 47. Insulin Glargine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…- 世界の動物用インスリン市場規模・現状・予測（2021年-2027年） Animal insulin is derived from cows and pigs. Animal insulin was the first type of insulin to be administered to humans to control diabetes. Until the 1980s, animal insulin was the only treatment for insulin dependent diabetes. Currently, the use of animal insulin has been largely replaced by human …
- インスリンポンプのグローバル市場2021 An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processi…
- 世界のプレミックスインスリン市場規模・現状・予測（2021年-2027年） Premix Insulin is a combination of two insulins mixed together: one insulin that is short-acting or fast-acting, plus one insulin that is intermediate-acting. Premix Insulin can reduce postprandial blood glucose and reduce fasting blood glucose. According to the variety, premixed insulin can be divi…
- ペンインスリン注射器のグローバル市場調査 2019年 The global Pen Insulin Syringe market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pen Insulin Syringe volume and value at global level, regional level and company level. From a global perspective, this…